Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 4:11 PM ET

Date/Time Source News Release
12/19/2024 07:30 AM EST Newsfile Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK
12/02/2024 04:00 PM EST Newsfile First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)
11/13/2024 04:05 PM EST Newsfile Adaptimmune Reports Q3 2024 Financial and Business Updates
11/13/2024 09:00 AM EST Newsfile Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial
11/05/2024 09:19 AM EST Newsfile Adaptimmune to Participate in Scientific and Medical Conferences this November and December
10/31/2024 05:20 PM EDT Newsfile Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
09/20/2024 08:35 AM EDT GlobeNewswire Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
09/16/2024 12:07 PM EDT GlobeNewswire Life Sciences Virtual Investor Forum Agenda Announced for September 19th
08/12/2024 07:00 AM EDT Newsfile Adaptimmune Reports Q2 2024 Financial and Business Updates
08/05/2024 08:00 AM EDT Newsfile Adaptimmune to Report Q2 2024 Financial and Business Updates on Monday, August 12, 2024
Page

Additional News

As of January 3, 2025 • 4:11 PM ET

Date/Time Source News Release
11/13/2024 07:48 PM EST SeekingAlpha Adaptimmune Therapeutics plc (ADAP) Q3 2024 Earnings Call Transcript
11/13/2024 06:14 PM EST SeekingAlpha Adaptimmune GAAP EPS of -$0.01 beats by $0.07, revenue of $40.9M beats by $20.41M
11/13/2024 04:46 PM EST SeekingAlpha Adaptimmune to engage in restructuring; 33% headcount reduction
11/13/2024 10:00 AM EST SeekingAlpha Here are the major earnings after the close today
11/13/2024 09:27 AM EST SeekingAlpha Adaptimmune reports positive data in mid-stage trial of its sarcoma treatment
11/13/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, November 13th, 2024
11/13/2024 04:31 AM EST US Earnings Reports Expected earnings - Adaptimmune Therapeutics plc
09/12/2024 08:38 AM EDT SeekingAlpha Adaptimmune's T-Cell Therapy Journey: A Small Market, Big Ambitions
08/12/2024 11:42 AM EDT SeekingAlpha Adaptimmune Therapeutics plc (ADAP) Q2 2024 Earnings Call Transcript
08/12/2024 10:10 AM EDT InvestorIdeas.com Medical Tech and Biotech Stocks to Watch and the Treatments for Solid Tumors
Page